Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant global health challenge, particularly in resource-limited settings. This article presents a comprehensive approach to the effective management of enteric fever, reinforcing the importance of early diagnosis, appropriate antibiotic therapy, and preventive measures.
Early diagnosis is crucial in managing enteric fever. Rapid diagnostic tests (RDTs) are gaining acceptance due to their ease of use and quick turnaround. However, their sensitivity and specificity vary. Blood culture remains the gold standard for diagnosis, although it may not always be feasible in resource-limited settings.
Antibiotic resistance is a growing concern in the treatment of enteric fever. Empirical therapy should ideally be guided by local antimicrobial susceptibility patterns. Fluoroquinolones, third-generation cephalosporins, and azithromycin are commonly used. Duration of therapy typically ranges from 7 to 14 days, depending on the patient's clinical response.
Prevention of enteric fever largely depends on improving sanitation and access to clean water. Vaccination also plays a crucial role. Both Vi polysaccharide and Ty21a vaccines are recommended for high-risk populations and travelers to endemic areas. However, their protective efficacy is not 100%, underscoring the need for complementary preventive measures.
Managing enteric fever effectively requires a multi-faceted approach. Early diagnosis, appropriate antibiotic therapy, and preventive measures are all integral components. As healthcare professionals, it is our responsibility to stay updated with the latest diagnostic tools, understand local antibiotic resistance patterns, and advocate for improved sanitation and vaccination programs. This comprehensive strategy will help us reduce the burden of this preventable disease.
1.
New drug combination shows good results in patients with HPV-negative head and neck cancer
2.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
3.
Asian Women With Breast Cancer Outlive White Peers
4.
What Comes After Cancer?
5.
An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.
1.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
2.
Spatial Transcriptomics in Oncology: Transforming Tumor Biology and Precision Medicine
3.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
4.
Endurance Training in Hematologic Disease: Current Perspectives and Clinical Implications
5.
Cowden Syndrome and Cancer: Understanding the Risk Factors
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Understanding Common Causes of Abnormal Blood Counts
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
Diagnosis and Management in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation